Frank A. D'Amelio Named CFO of Pfizer

September 13, 2007
BioPharm International Editors

Frank A. D'Amelio has been named senior vice president and chief financial officer of Pfizer (New York, NY, www.pfizer.com), effective in mid-September.

Frank A. D’Amelio has been named senior vice president and chief financial officer of Pfizer (New York, NY, www.pfizer.com), effective in mid-September. D’Amelio has almost three decades of operating and financial experience at AT&T, Lucent Technologies, and Alcatel-Lucent, having served as both chief operating officer and chief financial officer at Lucent.

He succeeds Alan Levin, whose resignation from Pfizer was announced in May.